| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2875568 | The Annals of Thoracic Surgery | 2011 | 6 Pages |
Abstract
Tumor necrosis was shown to be an adverse risk factor for survival and recurrence in patients with stage IA NSCLC. Thus, close observation and individualized adjuvant therapy might be helpful for patients with stage IA NSCLC with tumor necrosis.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Seong Yong MD, Hyun-Sung MD, PhD, Hee-Jin MD, Geon Kook MD, PhD, Kyung Young MD, Jae Ill MD, PhD,